Perfusion imaging has had modest success thus far in mood disorder.The most consistent findings in both primary major depression and in secondary depression have been reductions in inferior frontal cortex, adjacent cingulate cortex, temporal cortex and basal nuclei.They are compatible with a primary network for the integration of emotional experience in inferior frontal cortex, striatum and amygdala which is partially supported by the findings from relevant lesions and activation studies in normal controls.There are additional findings implicating dorso-lateral prefrontal and adjacent medial/limbic cortex in some patient groups. In elderly men particularly, reductions in prefrontal cortex appear to correlate with cognitive impairment.
and fMRI. The technical background to these methodologies can be found in appropriate review articles 1 " 3 , although understanding the physics is less important than understanding the physiology. The energy supply for neurones comes primarily from glucose which must be delivered to the brain continuously by its blood supply. Uptake of nonmetabolisable 2-deoxyglucose (2-DG) gives a measure of this process 4 and a method based on 18 F-2-DG is available for PET studies in man. In practice, this fully quantitative measure of metabolism must be made over 30 min or more, which is inconveniently long and requires relatively high radiation exposure. However, regional brain perfusion or blood flow is also intimately yoked to local neuronal activity and thereby to local neuronal metabolism. Detecting regional perfusion allows the sampling of brain activity over a much shorter time interval than is possible with 2-DG. In addition, the signal associated with local dynamic changes in brain perfusion may actually exceed the demand for substrate and so amplify the relationship between neuronal activity and local blood supply 5 . Detection of brain perfusion forms the basis of 1J O-labelled water methods for PET and the 99m Tc-exametazime method for SPET. There is good reason to think that the measures from either method are closely correlated, although the SPET method cannot be made fully quantitative 6 . The relative uncoupling between supply of, and demand for, substrate is believed to form the basis for the T2* signal detected in the currently most widely adopted fMRI methodology 3 . Indeed, the term blood oxygen level dependent (BOLD) imaging has sometimes been used as a synonym for fMRI. More ways in which MRI may be adapted for measuring brain physiology are given elsewhere in this issue. fMRI has yet to make a significant contribution to our understanding of the functional anatomy of the affective disorders and dementias.
A few small problems
The disadvantages of all techniques for perfusion imaging lie in the uncertain relationships between perfusion, metabolism and neuronal activity. The activity of terminals is likely to dominate the metabolic response because large ionic fluxes will require more energetic compensation for small structures than for large ones. However, an 'increase' may, of course, represent activity in excitatory or inhibitory terminals. In relatively large and complex structures it is seldom likely to be possible to say what circuits are actually active and it seems quite possible that opposite effects of activation and de-activation may prevent a net signal. Even if the underlying change in neuronal metabolism has an unambiguous meaning, the coupling between it and local vascular response may have a different gain in different brain areas or during different transient processes; it is also unlikely to be strictly linear. This means that parametric studies that depend upon the magnitude of the signal must be subject to a variety of unknown biases. Finally, the vascular response imposes a rate limiting filter that will distort the potentially rapid underlying changes in neuronal activity.
The objections to perfusion imaging should not obscure its current practical importance in offering a unique means to identify the tomographic locations of dynamic changes in human brain function. It is a unifying method which brings together evidence from traditionally separate disciplines for the development of brain based cognitive neuroscience. It also has the potential for serving as a functional index of drug action in psychopharmacology; the actions of specific agonists or antagonists may allow inferences about the balance of regional neurotransmitter function in man (see Grasby et al., this issue). Finally, perfusion imaging offers the potential for looking at the differential effects of psychological activation in different morbid states.
Statistical analysis of the enormous number of measurements made in imaging studies has generated two main methods. In the simplest, regions of interest are drawn from an atlas or the aligned structural scans of the same patients and by combining data from large numbers of picture elements or pixels, the number of comparisons is reduced to a reasonable size. By contrast, a pixel-by-pixel approach allows functional regions of interest to be defined post hoc 7 (see also Friston, this issue). This is valuable when there are no compelling a priori hypotheses to identify a particular region or regions of interest and especially when focal effects are likely (e.g. in activation studies). Pixel-by-pixel analysis for comparisons of groups of subjects requires individual brain shapes to be transformed into standard co-ordinates and the higher spatial frequency signals of the images must be heavily filtered; it otherwise makes maximal use of all the available data. Region of interest analysis is most appropriate when the hypothesis to be tested assumes a defined anatomy and the effects being sought are relatively diffuse. So far the primary interest of perfusion imaging for psychiatric conditions has been in the investigation of baseline function where either approach appears potentially informative.
Major depression

Differences between depressed patients and controls or other patient groups
In a majority of studies, reductions of function in anterior brain structures have been described in depressed patients compared with controls. Table 1 summarises the findings using different scanning techniques and illustrates the important variations between them. Age is a particularly critical variable and reduced global flow is most likely in older subjects. Lateralised effects, while often discussed, are very inconsistent. Tomographic methods have usually localised the greatest hypoperfusion in frontal, temporal and parietal areas. In frontal regions, inferior or orbital cortex tends to be more consistently implicated than dorso-lateral pre-frontal cortex. The largest and most spatially extensive frontal reductions may be most likely in older patients and particularly in males. In PET and SPET studies, such reductions in function could be an expression of associated structural change in older subjects, although there has been a paucity of investigations that directly relate structural to functional images. In any case, CT or MRI would be inadequate to identify loss of terminals in vivo. There have been no attempts to relate in vivo imaging findings to post mortem findings in affective disorder and relatively few attempts even to follow-up patients and identify the associations between perfusion decrements and the prognosis, response to treatment or the subsequent risk of dementia.
The cross-sectional findings are compatible with the view that major depression is usually associated with extensive depression of function in predominantly anterior brain structures and the pathways that interconnect them. Cross-sectional observation does not establish whether such effects relate to temporary features of the depressed state, are permanent and enduring or represent some interaction between the two.
Cross-sectional correlations between perfusion and symptoms
If the differences between patients and controls were simply due to the neurophysiological activity underlying the depressed state, one would expect correlations between aspects of that state and the perfusion image. The states we call major depression are many and various. As well as depressed mood, patients may describe prominent anxiety, intrusive thoughts, motor agitation or retardation, impaired capacity for any form of effortful activity, impairment of concentration and memory, disturbance of appetite, sleep and sexual function, even delusions and hallucinations. Accordingly, the scales most commonly employed to measure depressive symptoms capture either overall severity, an approach best embodied by the Hamilton Scale 8 , or the type of symptoms present.
Correlations with the Hamilton Scale
Many of the studies reporting differences between patients and controls have also reported the association between regional perfusion in the depressed group and the severity of depression. Most of such studies have shown negative associations, i.e. a high Hamilton score tends to be associated with reduced uptake usually in those areas showing reductions compared with control series (Table 1) . Such findings provide preliminary support for the idea that differences from control groups represent, in part if not in whole, state changes, with the obvious prediction that reversal of the symptoms should see a normalisation of brain perfusion. However, by no means all the published studies have actually shown the expected negative correlation (Table 1) . Furthermore, the association appears to be most clear-cut in those subjects showing the most extensive frontal reductions. This is paradoxical because it is just those subjects, often elderly, in whom a contribution from enduring organic reductions in function might be expected. The corroborating finding of a reversal of the reduced function on treatment and recovery is described below.
Association between specific symptoms and regional brain perfusion
The syndrome of major depression is associated with impairment of neuropsychological function, particularly in the mnemonic and psychomotor domains. Measured neuropsychological decrements appeared to be good candidates for identifying the underlying regional involvement of brain areas in affective disorder and have been the subject of several studies in recent years. The first such study in younger patients with major depression 9 -10 showed relative sparing of fluency, block design and other conventional tests of dorso-lateral pre-frontal function and clear cut impairment of cognitive function in the mnemonic and psychomotor domains: the severity of depression was related to the impairment and there was a corresponding pattern of reduced perfusion with SPET implicating inferior frontal cortex and temporo-parietal cortex. The actual correlations between cognitive impairment and brain perfusion were confined to a relatively small number of areas in posterior cingulate cortex and basal nuclei 9 . The correlations were positive, implying increased activity as a critical correlate of impaired function and, perhaps, a failure to de-activate posterior cingulate cortex which is known to have an important role in complex attentional mechanisms 11 . A comparable correlation with increased perfusion in posterior cingulate cortex 12 was for a factor described as 'anxiety', but which also loaded weight loss, anergia, insomnia and agitation. These two studies were among the largest to employ tomographic imaging and although they clearly recruited slightly different patient populations, such a focal common finding may be worth highlighting. It raises the possibility that the level of activity in posterior cingulate cortex is a core determinant of the depressive state and the wide network of reciprocal connections to frontal areas may underlie a variety of the associated symptoms.
Factor analysis can always be used arbitrarily to reduce many measured clinical variables to a few dimensions, although it is unlikely to yield consistent results in different populations. It reached its fullest expression in the five publications that have resulted from the single cross-sectional 15 O-PET study of the MRC Cyclotron Unit on major depression 12 " 16 . The relationship between brain perfusion and the unrotated first principal component of the data set, which would have reflected severity, was not described. The factors loading cognitive impairment and retardation mapped to mesial frontal and adjacent cortex. This largely paralleled the finding with SPET for older male patients with marked frontal decrements which correlated with psychomotor slowing 17 . It seems quite possible that structural change may have contributed to these findings at the macroscopic 18 or microscopic levels. Functional imaging generates questions for other disciplines better equipped directly to address the functional integrity of frontal projections in the elderly 19 .
Correlations with depressive sub-type
The best validated division of symptoms within the existing literature relates to the difference between endogenous or melancholic symptoms and the neurotic pattern, traditionally seen as reactive to life events. It was claimed that patients could be dichotomised into groups showing primarily endogenous and primarily neurotic patterns of illness using the Newcastle Scale 20 , although more recently it has been argued that the scale represents a dimension 21 . Despite its arbitrary nature, interest is now justified by the association between Newcastle Scale scores and ratings on the CORE system, a sign rather than a symptom-based typology for depression which may embody the critical association between melancholic or endogenous illnesses and motor disorder 22 .
Austin et aP showed increased uptake in dorso-lateral pre-frontal cortex in association with high Newcastle Scores. This finding may imply a tendency for younger, more endogenous patients to show uptake which may even exceed control values, as in a highly selected group with strong family history 23 . What is unsure is whether ongoing mental state characteristics are different in such patients. It is possible, for example, that increased frontal activity reflects increased activation in association with frequent negative thoughts or ruminations. Reductions may be more likely in patients with impoverished mental states.
Limitations of the correlational approach
It is a strong expectation that the pattern of brain perfusion should reflect the pattern of activity in an ongoing mental state. In schizophrenia, the intrinsic variability of the mental state has been invoked as a reason for preferring activation studies to those conducted at baseline 24 but depressive illness is much more clearly a stable albeit temporary state. Thus far, all imaging studies have tended to be, to a greater or lesser extent, confirmatory of the general hypothesis that depressive symptoms and the existence of a depressive illness is associated with particular patterns of abnormal activity in the brain; they have not served to take us very much further forward and to do so will require more imaginative experimental designs that address more critical models of the illnesses.
It will be possible specifically to investigate the core functions in depression, such as motivation and reward mechanisms, effortful capacity or mnemonic function. The functional anatomy of such constructs should lie within those areas frequently shown to be abnormal in depressive illness. The further apparently logical step is to carry the appropriate activation tasks into depressed patients. The particular difficulty is then how to treat discrepant performance between patient and control groups when designing comparison studies. Encoding operations, as distinct from active or efferent processes may be easier to study, but this risks ignoring critical components of the depressed state. One may define the problem to be identification of abnormal processing in patients versus controls when external performance is appropriately matched. This usually requires pacing of normal performance to match it with the abnormal performance of patients. A different pattern of activation for patients versus controls would be a novel reflection of the brain activity that underlies the depressed state. If we knew that the particular operation represented a core abnormality in depressive illness which predicted both symptoms, response to treatment, modulation by neurotransmitter challenge and outcome, then we might have a very strong argument for saying that it is the critical network involved in affective disorder.
If a task is so fundamental to a disorder that subjects are almost unable to perform it, then we might expect, simply, no activation. Some early activation studies in dementia effectively used activations the subjects could not do, with this potentially uninteresting result 25 . Failure to activate a particular network becomes interesting if it can be shown that the same areas can be activated normally by dissociated tasks (i.e. tasks the patients can perform). This generates an alternative argument that the failure to activate a brain network for a critical task defines the abnormality that underlies the illness more precisely than a test of the sort defined in the previous paragraph. Indeed, the process of matching performance in patients and controls may run the risk of identifying spurious differences between the groups. This is effectively the argument used to defend the use of the Wisconsin Card Sort Test as a challenge for schizophrenia 26 .
Activation studies
The choice of activation study will obviously follow from our hypotheses of what forms the core of mood disorder. Explicit inclusion of mood related experience or judgement appears to have face validity. There have already been several studies of mood induction employing standard procedures. Pardo et aP- 7 described increases in inferior orbito-frontal cortex comparing a sad state with baseline. George et aPs described more widespread activation of bilateral cingulate, medial prefrontal and medial temporal cortex, basal ganglia and thalamus in a better controlled design. Interestingly, happiness produced widespread frontal, temporal and parietal reductions in perfusion compared with the sad state. The sign of the perfusion effects is thus the opposite of that expected from the clinical finding of reductions in perfusion in limbic, frontal and basal nuclei. It raises the paradoxical but interesting possibility that the patterns of reduced perfusion seen in clinical depression are dominated by mechanisms usually involved in mood enhancement.
More complex studies of emotional recognition and memory will be of great interest. A preliminary study to identify the brain regions involved in detecting emotional cues from faces has again implicated orbitofrontal and cingulate activation in volunteers 28 . A bilateral lesion-of the amydala disrupts the recognition of facial emotion rather specifically 29 . The representation of emotion as an attribute of others and as a personal experience could share common pathways and imaging will allow a direct approach to the problem. The way in which both relate to autonomic function has been given impetus by the findings of a disrupted autonomic response to social stimuli in sociopathic patients with orbitofrontal lesions 30 . The prototype for such patients may have been Phineas Gage whose precise injury has been the subject of recent reconstruction 31 . Understanding the social experience of patients in neurophysiological terms appears incredibly audacious but who is to say that our understanding of affective disorder may not depend ultimately upon it.
Serial changes on recovery
The most striking difference between depressive illness and other functional psychoses like schizophrenia and, indeed, Alzheimer's disease, is that recovery of function is, at least in principle, complete and can be facilitated by specific psychopharmacological interventions. One of the simplest ways around the empirical difficulties with correlational studies is to examine the changes that take place when patients recover from illness. Within-subject partitioning of variance should then give a powerful indication of where in the brain change occurs most strikingly with treatment. Unfortunately, the number of patients entered in such studies has been small, not all recover or can be studied drug free and the findings are by no means consistent (Table 2) ; most implicate basal ganglia and mesial frontal cortex. We published the first and largest of the series using three dimensional tomography and region of interest analysis 32 . In those patients who recovered best and could be matched drug free before and after a course of treatment, changes were localised to inferior anterior cingulate cortex and basal ganglia. Localisation of changes in basal ganglia and medial frontal cortex may implicate dopaminergic projections. A number of studies have also described normalisation of regional perfusion in dorso-lateral prefrontal cortex on recovery from depression and changes in basal ganglia (Table 2) .
Bench et al 33 also found changes in mesial frontal/cingulate cortex, but in a more superior location corresponding to the area showing the greatest reductions when the patients were most depressed. The analysis of test/retest data using pixel-by-pixel approaches must run a risk of detecting effects primarily due to regression to the mean. Other evidence of short term changes in cingulate cortex has come from sleep deprivation, where, for responders, two groups 34 - 35 have described relative hyperperfusion in anterior cingulate cortex in the depressed state with normalisation in the recovered state. The short-term effects of electroconvulsive therapy were also in this area and correlated with Hamilton scores 36 . The reductions in brain perfusion seen with ECT persist after completion of treatment and are greatest in the responders 37 ; the dissociation of ECT effect upon perfusion from the direction of effect expected with recovery is interesting.
Secondary depression
There have been a number of studies in which the pattern of brain perfusion associated with depressive symptoms have been described in patients with a primary organic diagnosis. In Parkinson's disease, a maximal decrement has been localised to superior medial frontal cortex comparable with the previous work of the same group in primary unipolar depression 38 . However, echoing the more common pattern in major depression (Table 1) , other studies have found depressive symptoms to be associated more with inferior frontal cortex, and associated limbic areas (in Parkinsons's disease 39 , Huntington's disease 40 ). The finding of this pattern of disturbance in patients with basal ganglia disease lends strength to the idea that the inter-connections between inferior frontal cortex and basal ganglia are involved in the expression of depressive symptoms. By contrast, in Alzheimer-type dementia, more depressed patients showed increased decrements in parietal and temporal cortex 41 . While there is clearly the potential for teasing out different aspects of mood disorder and cognitive impairment on the basis of dissociation between either individuals or groups of patients, so far the findings have done little more than confirm what has been seen already in primary affective disorder.
Studies in the dementias
Difference between demented patients and controls or other patient groups As has already been emphasised, perfusion imaging primarily gives an indication of anatomical localisation of abnormal functions. While this has been of some interest in diagnosing and sub-dividing the dementias, the real advances in diagnosis are likely to be molecular. There remains, nevertheless, an interest in the relationship between clinical symptoms and brain localisation, identification of early dementia and the measurement of change over time. Perfusion imaging should always be complementary to, rather than a substitute for careful neuropsychological investigations since there is little evidence that perfusion imaging is itself the more sensitive method.
There has been a consensus that Alzheimer-type dementia tends to show posterior decrements in perfusion 42^4 which can probably be correlated with reductions in the density of neuronal terminals in association cortex 45 . Those studies that have made this finding have been cross-sectional and have usually entered patients with moderate to severe dementia. The observation is of clinical relevance, and has prompted quite widespread application of SPET to diagnosis. However, clinical evaluation of perfusion SPET has usually remained subjective and rested on interpretation of images rather than measurement. There seems little reason not to quantify SPET images and express abnormalities in statistical terms, but this is only emerging slowly 4^"49 . The sensitivity and specificity of SPET imaging needs to be defined in a quantitative way for a particular clinical contrast. Perhaps the most important of such contrasts is that between depressed patients and patients with dementia, since cognitive impairment is a consistent and striking feature of depression in the elderly and may genuinely be confounded with dementia when it reaches levels that attract the term pseudodementia. Patients with wellpreserved posterior temporal perfusion and frontal deficits are more likely to be depressed than have Alzheimer dementia. The limits to this finding have been quantitatively illustrated for 99m Tc-exametazime SPET 17 and ^Xe 50 and in a more limited study with 18 F-DG PET 51 . More difficulty will arise if cases with early dementia rather than cases with established and often severe Alzheimer's disease are entered into cross-sectional comparisons with depressed patients. It is anecdotally true that there are occasions when a SPET scan is extremely useful either in showing an absolutely typical posterior temporal parietal perfusion deficit in a patient where there is, for one reason or another, real doubt about the diagnosis; this is supported by estimates of the sensitivity and specificity for SPET with qualitative rating 52 -53 . More rarely, frontal lobe dementias may be confused with affective states and will usually show obvious perfusion deficits. In practice, however, the clinical uncertainty frequently results from a poor appreciation of the value of formal neuropsychological testing. Where patients present early with isolated memory problems, the role of functional imaging is even less established and may require more quantitative high resolution images of the medial temporal cortex and hippocampus 54 . Finally, the old problem of distinguishing Alzheimer-type from multi-infarct dementia has been addressed at the level of clinical comparison 55 -56 . The findings suggest a variety of differences between the syndromes, but lack the necessary clinicopathological validations. The largest study which will allow such validation is the OPTIMA project which has already suggested that there may be a role for repeated testing or combining the SPET findings with structural scans in the diagnosis of Alzheimer-type dementia 57 ' 58 . The role of structural imaging in the investigation of Alzheimer's disease is reviewed by Smith and Jobst in this issue.
Cross-sectional correlation between perfusion and symptoms
Most studies have shown an association between the degree of dementia and the extent of perfusion decrements in a range of brain areas 59 " 62 . Left parietal perfusion seems to be particularly predictive of global cognitive impairment in probable Alzheimer's disease. By contrast, in Korsakoff s psychosis, it is frontal perfusion which appears to be correlated with cognitive difficulties 59 . In Huntington's disease, again despite primary sub-cortical pathology, cortical decrements are again correlated with clinical features 63 . As would be expected, frontal decrements are also associated with frontal presentations in some dementia syndromes 64 ' 65 . In the foregoing examples the neuropsychological measures averaged a very broad spread of the impairments or symptoms associated with the diagnoses of interest. Any correlation with affected brain regions in a cross-sectional series will have been heavily influenced by global severity. Potentially of more interest, is the identification of restricted cognitive deficits, for example in semantic memory, which might, in principle, be localisable by using perfusion imaging with careful statistical comparison of single brains against normal control series using pixel-by-pixel analysis.
Progression of disease and functional imaging
While serial decline is implied by the cross-sectional correlations between cognitive impairment and brain perfusion, the trajectory of decline in individual cases might prove to be a more sensitive measure than any cross-sectional comparison could hope to be. This certainly appears to be the case with structural measures of the medial temporal lobe (see Smith and Jobst, this issue), but the full integration of quantitative functional data into such studies is awaited. By the same token, either structural imaging or perfusion imaging could act as a surrogate marker for the effectiveness of treatments, were such to become available. For the moment, information on treatments is confined to acute effects of cholinesterase inhibitors in probable Alzheimer's dementia in which there are apparent increases in brain perfusion 66 . Interestingly, the primary action of cholinergic stimulation is to increase frontal perfusion. This may reflect the limited capacity of more directly damaged brain areas to respond to drug treatment and it may correspond to a role for frontal cortex in making the most of preserved perceptual, cognitive and executive abilities. SPET studies have also shown reversal of perfusion deficits following surgical interventions for hydrocephalus 67 - 68 and medical intervention for temporal arteritis 69 .
